Literature DB >> 556152

Timolol: short term "escape" and long term "drift".

W P Boger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 556152

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN： 0003-4886


× No keyword cloud information.
  7 in total

1.  Improved systemic safety and risk-benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma.

Authors:  Hannu Uusitalo; Mika Kähönen; Auli Ropo; Jukka Mäenpää; Gunilla Bjärnhall; Hans Hedenström; Väinö Turjanmaa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-21       Impact factor: 3.117

Review 2.  Pharmacological therapy for glaucoma: a review.

Authors:  P F Hoyng; L M van Beek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 3.  Topical drug therapy in glaucoma.

Authors:  Hemma Resch; Gerhard Garhofer
Journal:  Wien Med Wochenschr       Date:  2006-09

4.  Blind randomised non-crossover long-term trial comparing topical timolol 0.25% with timolol 0.5% in the treatment of simple chronic glaucoma.

Authors:  K B Mills
Journal:  Br J Ophthalmol       Date:  1983-04       Impact factor: 4.638

5.  Interaction of timolol and adrenaline.

Authors:  A Ohrström; O Kättström
Journal:  Br J Ophthalmol       Date:  1981-01       Impact factor: 4.638

6.  Effect of Timolol on Aqueous Humor Outflow Facility in Healthy Human Eyes.

Authors:  Arash Kazemi; Jay W McLaren; Matthew G J Trese; Carol B Toris; Vikas Gulati; Shan Fan; David M Reed; Tyler Kristoff; Jesse Gilbert; Sayoko E Moroi; Arthur J Sit
Journal:  Am J Ophthalmol       Date:  2019-02-19       Impact factor: 5.258

7.  The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland.

Authors:  K K Takki; A Klemetti; O Valle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.